Surgical prophylaxis in practice

Area of Science:

• Infectious Diseases
• Surgical Oncology
• Pharmacology

Background:

• Antibacterial prophylaxis is standard for clean-contaminated procedures.
• Prophylaxis in clean procedures traditionally focused on foreign-body implantation.
• Under-reporting of infections in non-prosthetic clean procedures suggests broader prophylaxis is needed.

Purpose of the Study:

• To review current guidelines for antibacterial prophylaxis in surgery.
• To evaluate the efficacy of different antibiotic agents for various surgical procedures.
• To propose improvements to surgical classification for better prophylaxis strategies.

Main Methods:

• Literature review of existing guidelines and evidence.
• Analysis of antibiotic spectrum and suitability for different surgical types.
• Evaluation of current surgical classification limitations.

Main Results:

• Cefazolin is recommended for clean-contaminated procedures, but broader spectrum agents (cefuroxime, cefamandole) are preferred for prosthetic surgery.
• Glycopeptides are reserved for high-risk MRSA cases.
• Specific procedures like colorectal, obstetric/gynecological, and gastrointestinal surgeries require broad-spectrum prophylaxis.
• Current guidelines are not always followed due to limitations in surgical classification.

Conclusions:

• Antibacterial prophylaxis should be considered for non-prosthetic clean procedures like breast surgery and herniorrhaphy.
• Antibiotic choice should be tailored to procedure type and potential pathogens, including anaerobic and MRSA coverage where necessary.
• A revised surgical classification incorporating patient risk factors is needed to improve guideline adherence and optimize prophylaxis strategies.